Circulating inhibitor of gonadotropin releasing hormone secretion by hypothalamic neurons in uremia.

BACKGROUND Previous studies have suggested a neuroendocrine defect underlying uremic hypogonadism, characterized by a reduced secretion of gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH). METHODS We studied the GnRH-producing GT1-7 cell line and the LH-producing LbetaT-2 pituitary cell line under uremic conditions to investigate whether substances circulating in uremic plasma directly affect hypothalamic or pituitary hormone secretion. The cells were incubated with serum from 5/6-nephrectomized or sham-nephrectomized castrated rats, respectively. Furthermore, GT1 cells were incubated with delipidated sera, serum subfractions separated by molecular weight, or several peptide hormones. Cellular viability, apoptosis rate and extracellular hormone degradation were assessed separately. GnRH and LH were measured by RIA in supernatants and cell lysates. GnRH gene expression was assessed by Northern blot. RESULTS Uremic serum caused a reduction of extracellular GnRH concentration by 31%, whereas intracellular GnRH increased by 12%. This effect was independent of serum lipids and enzymatic GnRH degradation but was abolished by trypsin digestion. Cellular viability, apoptosis rates and GnRH gene expression did not differ between the two groups. The inhibitory activity was recovered from the high-molecular weight fraction, whereas the fraction <5 kD had stimulatory activity. In contrast, uremic serum did not affect LH secretion from LbetaT-2 cells, indicating that the hypoactivity of the hypothalamo-pituitary gonadotrope unit results from an inhibition at the hypothalamic rather than the pituitary level. CONCLUSIONS Our results suggest that uremic serum contains macromolecular and hydrophilic peptide(s) able to specifically suppress the neurosecretion of GnRH from GT1-7 cells.

[1]  B. Tönshoff,et al.  Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease , 1996, Pediatric Nephrology.

[2]  E. Christensen Evidence for a decreased membrane recycling in the cells of renal proximal tubules exposed to high concentrations of ferritin , 2004, Cell and Tissue Research.

[3]  B. Tönshoff,et al.  Inappropriate elevation of serum leptin levels in children with chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. , 1998, Journal of the American Society of Nephrology : JASN.

[4]  A. Gore,et al.  Insulin-like growth factor-I effects on gonadotropin-releasing hormone biosynthesis in GT1-7 cells. , 1998, Endocrinology.

[5]  S. Tazuma,et al.  Transcytotic vesicle fusion with canalicular membranes is modulated by phospholipid species: Implications for biliary lipid secretion , 1997, Journal of gastroenterology and hepatology.

[6]  D. Brann,et al.  Expression and localization of the leptin receptor in endocrine and neuroendocrine tissues of the rat. , 1997, Neuroendocrinology.

[7]  D. W. Waring,et al.  The L beta T2 clonal gonadotrope: a model for single cell studies of endocrine cell secretion. , 1996, Endocrinology.

[8]  D. W. Waring,et al.  Steroid and pulsatile gonadotropin-releasing hormone (GnRH) regulation of luteinizing hormone and GnRH receptor in a novel gonadotrope cell line. , 1996, Molecular endocrinology.

[9]  R. D'Hooge,et al.  Guanidino compound levels in brain regions of non-dialyzed uremic patients , 1995, Neurochemistry International.

[10]  R. Rosenfeld,et al.  Alteration in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure. , 1994, The Journal of clinical endocrinology and metabolism.

[11]  C. Rao,et al.  Novel presence of luteinizing hormone/human chorionic gonadotropin (hCG) receptors and the down-regulating action of hCG on gonadotropin-releasing hormone gene expression in immortalized hypothalamic GT1-7 neurons. , 1994, Molecular endocrinology.

[12]  D. Dunger,et al.  Immunoreactive and bioactive luteinizing hormone in pubertal patients with chronic renal failure. Cooperative Study Group on Pubertal Development in Chronic Renal Failure. , 1994, Kidney international.

[13]  K. Schärer,et al.  In vivo alterations in the gonadotropin-releasing hormone pulse generator and the secretion and clearance of luteinizing hormone in the uremic castrate rat. , 1994, Neuroendocrinology.

[14]  P. Kelly,et al.  Inhibition of gonadotropin hormone-releasing hormone release by prolactin from GT1 neuronal cell lines through prolactin receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P. Licht,et al.  Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. , 1993, Endocrinology.

[16]  S. Harvey,et al.  Parathyroid hormone-induced dopamine turnover in the rat medial basal hypothalamus , 1993, Peptides.

[17]  A. Iranmanesh,et al.  Evidence for attenuation of hypothalamic gonadotropin-releasing hormone (GnRH) impulse strength with preservation of GnRH pulse frequency in men with chronic renal failure. , 1993, The Journal of clinical endocrinology and metabolism.

[18]  J. Roberts,et al.  Intrahypothalamic injection of a cell line secreting gonadotropin-releasing hormone results in cellular differentiation and reversal of hypogonadism in mutant mice , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. D'Hooge,et al.  Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice , 1992, Journal of the Neurological Sciences.

[20]  I. Horii,et al.  Effect of 1,25-dihydroxyvitamin D3 on the female reproductive system in rats. , 1992, The Journal of toxicological sciences.

[21]  W. Wetsel,et al.  Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hormone-secreting neurons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  W. Wetsel,et al.  Gonadotropin-releasing hormone neuronal cell lines. , 1992, Frontiers in neuroendocrinology.

[23]  David Handelsman,et al.  Regulation of hypothalamic gonadotropin-releasing hormone secretion in experimental uremia: in vitro studies. , 1991, Neuroendocrinology.

[24]  David Handelsman,et al.  Regulation of pulsatile luteinizing hormone secretion in experimental uremia. , 1991, Endocrinology.

[25]  G. Gilad,et al.  Polyamines can protect against ischemia-induced nerve cell death in gerbil forebrain , 1991, Experimental Neurology.

[26]  J. Windle,et al.  Immortalization of hypothalamic GnRH by genetically targeted tumorigenesis , 1990, Neuron.

[27]  W. Robertson,et al.  Pulsatile bioactive luteinizing hormone secretion in men with chronic renal failure and following renal transplantation. , 1990, Nephron.

[28]  David Handelsman,et al.  Hypothalamic opioid mechanisms in experimental uremic hypogonadism. , 1990, Endocrinology.

[29]  M. Orłowski,et al.  Inhibition of endopeptidase 24.15 slows the in vivo degradation of luteinizing hormone-releasing hormone. , 1989, The Journal of pharmacology and experimental therapeutics.

[30]  P. Goldwasser,et al.  Cholesterol and lipid disturbances in renal disease: the natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis. , 1989, The American journal of medicine.

[31]  M. Rowland,et al.  Pituitary response to LHRH during chronic renal insufficiency in the male rat. , 1989, Journal of andrology.

[32]  G. Gilad,et al.  Treatment with polyamines can prevent monosodium glutamate neurotoxicity in the rat retina. , 1989, Life sciences.

[33]  A. Heidland,et al.  Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin. , 1989, Clinical nephrology.

[34]  S. Massry,et al.  Hyperparathyroidism and hypotestosteronemia of acute renal failure. , 1988, American journal of nephrology.

[35]  R. Prince,et al.  Calcitriol deficiency with retained synthetic reserve in chronic renal failure. , 1988, Kidney international.

[36]  P. Romagnoli,et al.  Reinternalization of secretory proteins during membrane recycling in rat pancreatic acinar cells. , 1987, European journal of cell biology.

[37]  G. Ramirez,et al.  Testicular Defect: The Primary Abnormality in Gonadal Dysfunction of Uremia , 1987, Southern medical journal.

[38]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[39]  R. Holder,et al.  Pulsatility of luteinising hormone in men with chronic renal failure: abnormal rather than absent. , 1987, British medical journal.

[40]  R. Wilkinson,et al.  Hypothalamic-pituitary-adrenocortical suppression and recovery in renal transplant patients returning to maintenance dialysis. , 1986, The Quarterly journal of medicine.

[41]  M. Dornay,et al.  Early polyamine treatment accelerates regeneration of rat sympathetic neurons , 1986, Experimental Neurology.

[42]  B. Lacour,et al.  Plasma and pituitary content of growth hormone luteinizing hormone, and prolactin in uremic rats. Effects of chronic infusion of insulin. , 1986, Nephron.

[43]  David Handelsman,et al.  Testicular function in experimental uremia. , 1985, Endocrinology.

[44]  O. Rønnekleiv,et al.  A new antiserum with conformational specificity for LHRH: Usefulness for radioimmunoassay and immunocytochemistry , 1985, Peptides.

[45]  K. Asayama,et al.  Lipid Profiles and Lipase Activities in Children and Adolescents with Chronic Renal Failure Treated Conservatively or with Hemodialysis or Transplantation , 1984, Pediatric Research.

[46]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[47]  A. Saito,et al.  Serum levels of polyamines in patients with chronic renal failure. , 1983, Kidney international. Supplement.

[48]  E. Ritz,et al.  Skeletal growth in experimental uremia. , 1983, Kidney international. Supplement.

[49]  S. Massry,et al.  Impaired energy metabolism in skeletal muscle during phosphate depletion. , 1983, Kidney international.

[50]  K. Schärer,et al.  Hypothalamo-pituitary-gonadal axis in children with chronic renal failure. , 1983, Kidney international. Supplement.

[51]  G. Beastall,et al.  The pituitary-testicular axis of uraemic subjects on haemodialysis and continuous ambulatory peritoneal dialysis. , 1982, Acta endocrinologica.

[52]  M. Blackman,et al.  Excess in vitro secretion of the free alpha-subunit of the glycoprotein hormones by pituitary cells from chronically uremic rats. , 1982, Endocrinology.

[53]  M. Blackman,et al.  Decreased in vitro testosterone production by isolated Leydig cells from uremic rats. , 1982, Endocrinology.

[54]  D. Papahadjopoulos,et al.  Control of membrane fusion by phospholipid head groups. I. Phosphatidate/phosphatidylinositol specificity. , 1981, Biochimica et biophysica acta.

[55]  P. Woolf,et al.  Hypothalamic-pituitary-ovarian axis in uremic women. , 1979, The Journal of laboratory and clinical medicine.

[56]  M. Farquhar Recovery of surface membrane in anterior pituitary cells. Variations in traffic detected with anionic and cationic ferritin , 1978, The Journal of cell biology.

[57]  R. Atkins,et al.  The pituitary-testicular axis in men with chronic renal failure. , 1977, The New England journal of medicine.

[58]  B. Cham,et al.  A solvent system for delipidation of plasma or serum without protein precipitation. , 1976, Journal of lipid research.

[59]  N. Samaan,et al.  Growth hormone levels in severe renal failure. , 1970, Metabolism: clinical and experimental.